-
Leadiant Biosciences,
formerly known as Sigma-Tau
Industrie Farmaceutiche Riunite, was
founded in 1957 by
research chemist Claudio Cavazza. In 2018 Leadiant...
- Elapegademase-lvlr was
approved by the U.S. Food and Drug
Administration (FDA) in 2018.
Leadiant Biosciences was
awarded a
priority review voucher for its
development under...
-
Servier (1954– )
Laurus Labs (2005– )
Lavipharm (1911– )
Lawley (1995– )
Leadiant (1957– ) Leo (1908– )
Lexicon (1995– )
LIFSE (1947– )
Ligand (1987– ) Lijun...
-
Authority for
Consumers and
Markets in
respect of the
pricing policy of
Leadiant Biosciences Ltd,
formerly known as Sigma-Tau Rare Disease, for chenodeoxycholic...
-
Plaintiff VSL Pharmaceuticals, Inc. ("VSL"),
Defendant Leadiant Biosciences, Inc. ("
Leadiant") and
Defendant Alfasigma USA, Inc. ("Alfasigma")" (PDF)...
- www.science.org.
Retrieved 2025-01-12. "Abelcet
Package Insert" (PDF).
Leadiant Biosciences. Sigma-Tau Pharmaceuticals.
Retrieved 14 July 2022. Mesa-Arango...
- Pharmaceuticals, Inc. U.S. Food and Drug Administration. "Chenodeoxycholic acid
Leadiant (previously
Chenodeoxycholic acid sigma-tau)".
European Medicines Agency...
-
Malaria GlaxoSmithKline Rare
pediatric Revcovi Adenosine deaminase-SCID
Leadiant Biosciences Rare
pediatric Gamifant Haemophagocytic lymphohistiocytosis...
-
court do****ents: "Defendant VSL Inc., and its
licensees Alfasigma and
Leadiant,
having lost the
right to sell the De
Simone Formulation,
decided to manufacture...
- Tau,
Sigma tau, 07-07-24
Archived 18
April 2012 at the
Wayback Machine "
Leadiant Biosciences | Dave
Lemus promoted to
Chief Executive Officer of Sigma-Tau...
